Medical Affairs has never carried more strategic weight—or faced greater pressure to prove its value. Across Europe, leaders are confronting a paradox: while scientific exchange and insights have become central to launch success, most organizations still measure their impact in activities, not outcomes.
That question—what does meaningful impact look like in Medical Affairs today?—sits at the heart of this year’s Veeva Commercial Summit Europe, taking place 5–6 November in Madrid. More than a technology gathering, the Summit reflects a broader reckoning across life sciences: how to evolve from coordination to clarity, from volume to value.
This year’s discussions bring together the stakeholders redefining that shift—medical, commercial, and data leaders aligned on a shared mission to close the gap between evidence and adoption. Topics span the full continuum of engagement:
- How scientific exchange can measurably influence clinical practice and patient outcomes
- What new benchmarks will define Medical Affairs performance over the next decade
- Why collaboration between medical and commercial teams has become the new launch imperative
- And how data—particularly from solutions like Veeva Link—is enabling successful AI use cases, and changing the way companies identify experts, capture insights, and make decisions
During the summit, we’ll explore these themes in depth through two Summit features:
- “Demonstrating the Value of Medical Affairs” — insights from Christoph Bug on how the industry is rewriting the measurement playbook.
- “The Increasing Role of Medical in Go-to-Market Strategies” — with David Medina Tato on data-driven KOL engagement and how AI-enabled medical insights can accelerate launch readiness.
The 2025 Summit arrives at a critical moment. The mandate for Medical Affairs is no longer just to inform—but to lead.
Moe Alsumidaie is Chief Editor of The Clinical Trial Vanguard. Moe holds decades of experience in the clinical trials industry. Moe also serves as Head of Research at CliniBiz and Chief Data Scientist at Annex Clinical Corporation.
